Association between clinical use of lansoprazole and the risk of type 2 diabetes mellitus: a pharmacoepidemiological cohort study

BACKGROUND: Proton pump inhibitors (PPIs) are common and widely used for gastrointestinal-related disorders. Lansoprazole is one of PPIs with potential benefits of anti-inflammation, reduced oxidative stress, and anti-diabetes. The aims of this study are to determine whether lansoprazole imparts dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ming-Hsun, Wu, Wen‐Tung, Chen, Yong-Chen, Lin, Tsung-Kun, Chou, Yu‐Ching, Sun, Chien‐An
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170833/
https://www.ncbi.nlm.nih.gov/pubmed/37165435
http://dx.doi.org/10.1186/s13098-023-01051-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170833/
https://www.ncbi.nlm.nih.gov/pubmed/37165435
http://dx.doi.org/10.1186/s13098-023-01051-8

Ejemplares similares